- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials Sponsored by Molecular Insight Pharmaceuticals, Inc.
Total 39 results
-
Molecular Insight Pharmaceuticals, Inc.UnknownPheochromocytoma | ParagangliomaUnited States
-
Molecular Insight Pharmaceuticals, Inc.CompletedProstate CancerUnited States
-
Molecular Insight Pharmaceuticals, Inc.CompletedPheochromocytoma | Paraganglioma | Carcinoid
-
Molecular Insight Pharmaceuticals, Inc.Approved for marketingPheochromocytoma | ParagangliomaUnited States
-
Molecular Insight Pharmaceuticals, Inc.CompletedAcute Coronary SyndromeUnited States, Canada
-
Molecular Insight Pharmaceuticals, Inc.Withdrawn
-
Molecular Insight Pharmaceuticals, Inc.Completed
-
Molecular Insight Pharmaceuticals, Inc.Completed
-
Molecular Insight Pharmaceuticals, Inc.Completed
-
Molecular Insight Pharmaceuticals, Inc.TerminatedMetastatic MelanomaUnited States
-
Molecular Insight Pharmaceuticals, Inc.CompletedProstate CancerUnited States, Canada
-
Molecular Insight Pharmaceuticals, Inc.CompletedNeuroblastomaUnited States
-
Molecular Insight Pharmaceuticals, Inc.CompletedProstate CancerUnited States, Belgium, Italy, Czech Republic, Hungary, Netherlands, Poland, Russian Federation
-
Molecular Insight Pharmaceuticals, Inc.CompletedPheochromocytoma | ParagangliomaUnited States
-
Molecular Insight Pharmaceuticals, Inc.WithdrawnNeuroblastomaUnited States, Canada
-
Molecular Insight Pharmaceuticals, Inc.CompletedProstate CancerUnited States
-
Molecular Insight Pharmaceuticals, Inc.TerminatedPheochromocytoma | ParagangliomaUnited States
-
Molecular Insight Pharmaceuticals, Inc.Completed
-
University of IowaMolecular Insight Pharmaceuticals, Inc.WithdrawnNeuroendocrine Tumor | NeuroblastomaUnited States
-
Molecular Insight Pharmaceuticals, Inc.National Cancer Institute (NCI)Withdrawn
-
Miguel PampaloniMolecular Insight Pharmaceuticals, Inc.; Jubilant DraxImage Inc.Terminated
-
MingSight Pharmaceuticals, IncRecruitingChronic Lymphocytic Leukemia | Small Lymphocytic Lymphoma | Aggressive LymphomaUnited States
-
MingSight Pharmaceuticals, IncShenzhen MingSight Relin Pharmaceutical Co., LtdRecruitingChronic Lymphocytic Leukemia (CLL) | Small Lymphocytic Lymphoma (SLL) | Mantle Cell Lymphoma (MCL) | Diffuse Large B-cell Lymphoma (DLBCL) | Follicular Lymphoma (FL) | Relapsed or Refractory B-cell Lymphoma | Marginal Zone Lymphoma (MZL)China
-
MingSight Pharmaceuticals Pty LimitedCompletedSafety and PK in Healthy VolunteersAustralia
-
Shenzhen MingSight Relin Pharmaceuticals Co., Ltd.RecruitingSmall Lymphocytic Lymphoma | Lymphocytic LeukemiaChina
-
Bennett ChinNational Cancer Institute (NCI); Molecular Insights PharmaceuticalsCompletedHeart Failure | Neuroendocrine TumorsUnited States
-
Shenzhen MingSight Relin Pharmaceuticals Co., Ltd.Fountain Medical Development Co., Ltd.RecruitingDiabetic Retinopathy | Diabetic Macular Edema | Macular Edema | Type 2 Diabetes With Diabetic Macular Edema | Type 1 Diabetes With Diabetic Macular EdemaChina
-
OHSU Knight Cancer InstituteGenentech, Inc.; OSI PharmaceuticalsTerminatedMetastatic Colorectal CancerUnited States
-
DalCor PharmaceuticalsMedpace, Inc.; The Montreal Health Innovations Coordinating Center (MHICC); Roche...CompletedAcute Coronary SyndromeSweden, United States, Brazil, Bulgaria, France, Italy, Russian Federation, South Africa, Spain, Turkey, United Kingdom, Germany, Hungary, Poland, Romania, Canada, Argentina, Australia, Austria, Belgium, Chile, Czechia, Denmark, Finland, Isra... and more
-
OHSU Knight Cancer InstituteNational Cancer Institute (NCI); AMAG Pharmaceuticals, Inc.TerminatedBrain NeoplasmsUnited States
-
OHSU Knight Cancer InstituteNational Cancer Institute (NCI); GlaxoSmithKline; Millennium Pharmaceuticals,...TerminatedRecurrent Adult Diffuse Large Cell Lymphoma | Recurrent Grade 1 Follicular Lymphoma | Recurrent Grade 2 Follicular Lymphoma | Recurrent Grade 3 Follicular Lymphoma | Recurrent Mantle Cell LymphomaUnited States
-
OHSU Knight Cancer InstituteOregon Health and Science University; Progenics Pharmaceuticals, Inc.Not yet recruitingProstate Adenocarcinoma | Castration Resistant Prostate Cancer | Castration Sensitive Prostate CancerUnited States
-
OHSU Knight Cancer InstituteOregon Health and Science University; AMAG Pharmaceuticals, Inc.Withdrawn
-
OHSU Knight Cancer InstituteGenentech, Inc.; Oregon Health and Science University; Servier Pharmaceuticals...RecruitingStage II Pancreatic Cancer AJCC v8 | Stage III Pancreatic Cancer AJCC v8 | Stage IV Pancreatic Cancer AJCC v8 | Metastatic Pancreatic Adenocarcinoma | Locally Advanced Pancreatic Adenocarcinoma | Stage IIA Pancreatic Cancer AJCC v8 | Stage IIB Pancreatic Cancer AJCC v8United States
-
Molecular Research Center, Inc.Harrison Clinical Research; Camargo Pharmaceutical Services; Clin Data Services; BARC Global Central Laboratory and other collaboratorsUnknownRheumatoid ArthritisUnited States
-
National Institute of Allergy and Infectious Diseases...Eli Lilly and Company; National Heart, Lung, and Blood Institute (NHLBI); Gla... and other collaboratorsCompletedCovid19United States, Denmark, Greece, Nigeria, Poland, Singapore, Spain, Switzerland, Uganda, United Kingdom
-
National Institute of Allergy and Infectious Diseases...National Heart, Lung, and Blood Institute (NHLBI); University of Copenhagen; US... and other collaboratorsCompletedCOVID-19United States, Denmark, Greece, Nigeria, Poland, Singapore, Spain, Switzerland, Uganda, United Kingdom
-
Prof Brian LawlorKing's College London; Göteborg University; University College Dublin; Aristotle... and other collaboratorsCompletedAlzheimer's DiseaseGermany, Ireland, United Kingdom, France, Greece, Hungary, Italy, Netherlands, Sweden
-
Paul Richardson, MDM.D. Anderson Cancer Center; Memorial Sloan Kettering Cancer Center; Massachusetts... and other collaboratorsActive, not recruiting